Krishnankutty Sudhir, MD, PhD

Four-Year Outcomes of Multivessel Percutaneous Coronary Intervention With Xience V Everolimus-Eluting Stents

08/27/2019

Seung-Woon Rha , MD, PhD;

Kyung Woo Park , MD;

Ehtisham Mahmud , MD;

Anna Gaborro , MD;

Jin Wang , PhD;

Weiying Zhao , MD, PhD;

Krishnankutty Sudhir , MD, PhD;

Richard A. Shlofmitz , MD;

Michael S. Lee , MD, DPM, FACFAS, FACC, FSCAI;

We evaluated the long-term outcomes of multivessel compared with single-vessel percutaneous coronary intervention with Xience V everolimus-eluting stents in real-world patients.

We evaluated the long-term...

08/27/2019

Journal of Invasive Cardiology

Taxol-Based Eluting Stents ‚Äî From Theory to Human Validation: Clinical and Intravascular Ultrasound Observations<br />

08/01/2008

Heidi N. Bonneau , RN, MS;

Shinjo Sonoda , MD;

Toru Kataoka , MD;

Yasuhiro Honda , MD;

Peter J. Fitzgerald , MD, PhD;

Gary S. Mintz , MD;

Paul G. Yock , MD;

Krishnankutty Sudhir , MD, PhD;

Reduction of restenosis remains an important goal of percutaneous coronary interventions. Although coronary stents reduce the rate of primary restenosis compared with balloon angioplasty,1–3 20–30% of treated vessels still develop recurrent...

Reduction of restenosis remains...

08/01/2008

Journal of Invasive Cardiology

Original Contribution

Comparison of Vessel Response following Sirolimus-Eluting Stent Implantation as Assessed by Serial 3-D Intravascular Ultrasound

08/01/2008

Paul G. Yock , MD;

Krishnankutty Sudhir , MD, PhD;

Junya Ako , MD, PhD;

Yasuhiro Honda , MD;

Peter J. Fitzgerald , MD, PhD;

Katsuhisa Waseda , MD, PhD;

Ichizo Tsujino , MD, PhD;

Yoshihisa Shimada , MD, PhD;

Yoshihiro Morino , MD;

Yoichiro Hongo , MD;

Left anterior descending artery (LAD) lesions have been classically shown to be one of the independent predictors of adverse coronary events following percutaneous coronary interventions (PCI) compared with non-LAD lesions.1–3 Recent studies...

Left anterior descending artery...

08/01/2008

Journal of Invasive Cardiology

Original Contribution

Preprocedural Inflammation Does Not Affect Neointimal Hyperplasia following Everolimus-Eluting Stent Implantation

12/04/2009

Peter J. Fitzgerald , MD, PhD;

Shigeru Saito , MD;

Masao Yamasaki , MD, PhD;

Ichizo Tsujino , MD, PhD;

Paul G. Yock , MD;

Katsuhisa Waseda , MD, PhD;

Ryota Sakurai , MD;

Takao Shimohama , MD, PhD;

Takao Hasegawa , MD;

Daisaku Nakatani , MD, PhD;

Hiromasa Otake , MD, PhD;

Krishnankutty Sudhir , MD, PhD;

Wesley Pierson , PhD;

Gregg W. Stone , MD, FACC, FSCAI;

Junya Ako , MD, PhD;

Hyeonsoo Chang , MSME;

Bon-Kwon Koo , MD, PhD;

Yasuhiro Honda , MD;

ABSTRACT: Background. Preprocedual C-reactive protein (CRP) has been reported to correlate with in-stent restenosis following bare-metal stent implantation. The aim of this study was to investigate the impact of preprocedural inflammation on...

ABSTRACT: Background....

12/04/2009

Journal of Invasive Cardiology

Original Contribution

Mid-Term Results of Everolimus-Eluting Stent in a Japanese Population Compared With a US Randomized Cohort: SPIRIT III Japan Registry With Harmonization by Doing

08/29/2012

Alexandra J. Lansky , MD;

Krishnankutty Sudhir , MD, PhD;

Takaaki Isshiki , MD;

Tadashi Kikuchi , MD, PhD;

Hiroshi Nonogi , MD, PhD;

Keiichi Igarashi , MD;

Kenshi Fujii , MD;

Kumiko Saito , MS, MPH;

Hiroshi Fujita , MD;

Shigeru Nakamura , MD;

Shigeru Saito , MD;

Kazuaki Mitsudo , MD;

Masato Nakamura , MD;

Takeshi Kimura , MD;

Hauro Hirayama , MD, PhD;

Gregg W. Stone , MD, FACC, FSCAI;

Yasuhiro Honda , MD;

Peter J. Fitzgerald , MD, PhD;

Katsuhisa Waseda , MD, PhD;

Abstract: To address safety concerns with first-generation drug-eluting stents (DESs), the everolimus-eluting stent (EES) has been developed as a second-generation DES. The study aim was to: (1) demonstrate that use of the EES in Japanese...

Abstract: To address safety...

08/29/2012

Journal of Invasive Cardiology